CD39 and CD161 Modulate Th17 Responses in Crohn's Disease
Aiping Bai(BioSense (United States)), Simon C. Robson(Beth Israel Deaconess Medical Center), Yi Zheng(Cincinnati Children's Hospital Medical Center), Wenda Gao(Hebei Medical University), Maria Serena Longhi(Beth Israel Deaconess Medical Center), Adam S. Cheifetz(Beth Israel Deaconess Medical Center), Alan C. Moss(Action Against Medical Accidents), Yan Wu(Sun Yat-sen University), Xiaofeng Sun(Lanzhou Petrochemical Polytechnic), Efi Kokkotou(Beth Israel Deaconess Medical Center), Anny Usheva(Beth Israel Deaconess Medical Center)
Cited by 91
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928